Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults

References

• Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
   PubMed Web of Science ®Google Scholar
• Bschor T, Adli M. Treatment of depressive disorders. Dtsch Arztebl Int. 2008;105:782–792.
   PubMed Web of Science ®Google Scholar
• Bschor T. Therapy-resistant depression. Expert Rev Neurother. 2010;10(1):77–86.
   PubMed Web of Science ®Google Scholar
• Bschor T, Bauer M, Adli M. Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int. 2014;111(45):766–775.
   PubMed Web of Science ®Google Scholar
• APA. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. 2010. Arlington (VA): American Psychiatric Association.
   Google Scholar
• Lam RW, Kennedy SH, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord. 2009;117 Suppl 1:S26–43.
   PubMed Web of Science ®Google Scholar
• Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007;8(2):67–104.
   PubMed Web of Science ®Google Scholar
• Bauer M, Pfennig A, Severus E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14(5):334–385.
   PubMed Web of Science ®Google Scholar
• DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (eds.), on behave of the Guideline Group on Unipolar Depression. S3-guideline/national disease management guideline unipolar depression. Berlin, Düsseldorf: DGPPN, ÄZQ, AWMF; 2009.
   Google Scholar
• NICE Depression. The treatment and management of depression in adults. In: NICE clinical guideline. Leicester (UK): National Collaborating Centre for Mental Health; 2009.
   Google Scholar
• Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry. 2012;200(5):393–398.
   PubMed Web of Science ®Google Scholar
• Pratt LA, Brody DJ, Gu Q. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief. 2011;76(76):1–8.
   PubMedGoogle Scholar
• Schwabe U, Paffrath D, editors. Arzneiverordnungs report 2015: Aktuelle Daten, Kosten, Trends und Kommentare. Berlin, Heidelberg: Springer; 2015.
   Google Scholar
• Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330(7488):396.
   PubMed Web of Science ®Google Scholar
• Huhn M, Tardy M, Spineli LM, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry. 2014;71(6):706–715.
   PubMed Web of Science ®Google Scholar
• Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology. 2012;37(4):851–864.
   PubMed Web of Science ®Google Scholar
• Leucht C, Huhn M, Leucht S. Amitriptyline versus placebo for major depressive disorder. Cochrane Database Syst Rev. 2012;12:CD009138.
   Google Scholar
• Arroll B, Elley CR, Fishman T, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev. 2009;3:CD007954.
   PubMed Web of Science ®Google Scholar
• Leucht S, Hierl S, Kissling W, et al. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry. 2012;200(2):97–106.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653–661.
   PubMed Web of Science ®Google Scholar
• Klein D. Listening to meta-analysis but hearing bias. Prev Treat. 1998;1(2):Article 0006c.
   Google Scholar
• Klein D. Reducing noise and hearing placebo more clearly. Prev Treat. 1998;1(1):Article 0008r.
   Google Scholar
• Fountoulakis KN, Moller HJ. Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol. 2011;14(3):405–412.
   PubMed Web of Science ®Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47–53.
   PubMed Web of Science ®Google Scholar
• Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790–792.
   PubMed Web of Science ®Google Scholar
• Khan A, Khan SR, Leventhal RM, et al. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Int J Neuropsychopharmacol. 2001;4(2):113–118.
   PubMed Web of Science ®Google Scholar
• Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry. 2000;57(4):311–317.
   PubMed Web of Science ®Google Scholar
• Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ. 2005;330(7488):385.
   PubMed Web of Science ®Google Scholar
• Hammad TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol. 2006;26(2):203–207.
   PubMed Web of Science ®Google Scholar
• Healy D, Whitaker C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci. 2003;28(5):331–337.
   PubMed Web of Science ®Google Scholar
• Högberg G, Antonuccio DO, Healy D. Suicidal risk from TADS study was higher than it first appeared. Int J Risk Saf Med. 2015;27(2):85–91.
   PubMedGoogle Scholar
• Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.
   PubMed Web of Science ®Google Scholar
• Isacsson G. Suicide prevention–a medical breakthrough? Acta Psychiatr Scand. 2000;102(2):113–117.
   PubMed Web of Science ®Google Scholar
• Lu CY, Zhang F, Lakoma MD, et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014;348:g3596.
   PubMed Web of Science ®Google Scholar
• Kamat MA, Edgar L, Niblock P, et al. Association between antidepressant prescribing and suicide rates in OECD countries: an ecological study. Pharmacopsychiatry. 2014;47(1):18–21.
   PubMed Web of Science ®Google Scholar
• Bschor T, Baethge C. No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy. Acta Psychiatr Scand. 2010;121(3):174–179.
   PubMed Web of Science ®Google Scholar
• Romera I, Perez V, Menchon JM, et al. Early switch strategy in patients with major depressive disorder: a double-blind, randomized study. J Clin Psychopharmacol. 2012;32(4):479–486.
   PubMed Web of Science ®Google Scholar
• Souery D, Serretti A, Calati R, et al. Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. World J Biol Psychiatry. 2011;12(5):364–375.
   PubMed Web of Science ®Google Scholar
• Kirsch I, Sapirstein G. Listening to prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treat. 1998;1:Article 0002a.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Stolk P, Ten Berg MJ, Hemels ME, et al. Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother. 2003;37(12):1891–1899.
   PubMed Web of Science ®Google Scholar
• Rief W, Nestoriuc Y, Weiss S, et al. Meta-analysis of the placebo response in antidepressant trials. J Affect Disord. 2009;118(1–3):1–8.
   PubMed Web of Science ®Google Scholar
• Hypericum-Depression-Trial-Group. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287(14):1807–1814.
   PubMed Web of Science ®Google Scholar
• Chen JA, Papakostas GI, Youn SJ, et al. Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group. J Clin Psychiatry. 2011;72(12):1669–1676.
   PubMed Web of Science ®Google Scholar
• Sinyor M, Levitt AJ, Cheung AH, et al. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry. 2010;71(3):270–279.
   PubMed Web of Science ®Google Scholar
• Sneed JR, Rutherford BR, Rindskopf D, et al. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry. 2008;16(1):65–73.
   PubMed Web of Science ®Google Scholar
• Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database Syst Rev. 2004;1:CD003012.
   Google Scholar
• Köhler S, Unger T, Hoffmann S, et al. Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study. Pharmacopsychiatry. 2013;46(2):69–76.
   PubMed Web of Science ®Google Scholar
• Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009;166(5):599–607.
   PubMed Web of Science ®Google Scholar
• Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252–260.
   PubMed Web of Science ®Google Scholar
• Perahia DG, Wang F, Mallinckrodt CH, et al. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Psychiatry. 2006;21(6):367–378.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389.
   PubMed Web of Science ®Google Scholar
• Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. BMJ. 2005;331(7509):155–157.
   PubMed Web of Science ®Google Scholar
• Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis. Br J Psychiatry. 2000;177:292–302.
   PubMed Web of Science ®Google Scholar
• Heres S, Davis J, Maino K, et al. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry. 2006;163(2):185–194.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44(6):195–235.
   Web of Science ®Google Scholar
• Bauer M, Pfennig A, Linden M, et al. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. J Clin Psychopharmacol. 2009;29(4):327–333.
   PubMed Web of Science ®Google Scholar
• Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry. 2006;59(11):1029–1038.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.
   PubMed Web of Science ®Google Scholar